ARTICLE | Company News
Mivac, Synthon deal
June 6, 2011 7:00 AM UTC
Synthon partnered with Mivac Development to research and develop multiple sclerosis (MS) candidates. The partners will use Mivac's tolerance-inducing fusion protein technology to research and screen l...